EE200200429A - Kolesteroolestri ja vahaestri sünteesi duaalsed inhibiitorid rasunäärme häirete jaoks - Google Patents
Kolesteroolestri ja vahaestri sünteesi duaalsed inhibiitorid rasunäärme häirete jaoksInfo
- Publication number
- EE200200429A EE200200429A EEP200200429A EEP200200429A EE200200429A EE 200200429 A EE200200429 A EE 200200429A EE P200200429 A EEP200200429 A EE P200200429A EE P200200429 A EEP200200429 A EE P200200429A EE 200200429 A EE200200429 A EE 200200429A
- Authority
- EE
- Estonia
- Prior art keywords
- ester
- sebaceous gland
- dual inhibitors
- gland disorders
- synthesis
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/255—Esters, e.g. nitroglycerine, selenocyanates of sulfoxy acids or sulfur analogues thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/08—Antiseborrheics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/10—Anti-acne agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Dermatology (AREA)
- Emergency Medicine (AREA)
- Epidemiology (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US17977800P | 2000-02-02 | 2000-02-02 | |
| PCT/US2001/002190 WO2001056556A2 (en) | 2000-02-02 | 2001-01-23 | Dual inhibitors of cholesteryl ester and wax ester synthesis for sebaceous gland disorders |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| EE200200429A true EE200200429A (et) | 2003-12-15 |
Family
ID=22657957
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| EEP200200429A EE200200429A (et) | 2000-02-02 | 2001-01-23 | Kolesteroolestri ja vahaestri sünteesi duaalsed inhibiitorid rasunäärme häirete jaoks |
Country Status (34)
| Country | Link |
|---|---|
| US (2) | US6730703B2 (pt) |
| EP (1) | EP1263421B1 (pt) |
| JP (1) | JP2003531113A (pt) |
| KR (1) | KR20020073574A (pt) |
| CN (1) | CN1398182A (pt) |
| AP (1) | AP2002002612A0 (pt) |
| AT (1) | ATE295724T1 (pt) |
| AU (1) | AU781563B2 (pt) |
| BG (1) | BG107042A (pt) |
| BR (1) | BR0107954A (pt) |
| CA (1) | CA2398219A1 (pt) |
| CR (1) | CR6712A (pt) |
| DE (1) | DE60110897T2 (pt) |
| DZ (1) | DZ3288A1 (pt) |
| EA (1) | EA004255B1 (pt) |
| EE (1) | EE200200429A (pt) |
| ES (1) | ES2239145T3 (pt) |
| GE (1) | GEP20043286B (pt) |
| HR (1) | HRP20020717A2 (pt) |
| HU (1) | HUP0301010A3 (pt) |
| IL (1) | IL150865A0 (pt) |
| IS (1) | IS6478A (pt) |
| MA (1) | MA26872A1 (pt) |
| MX (1) | MXPA02007309A (pt) |
| NO (1) | NO20023659L (pt) |
| NZ (1) | NZ520330A (pt) |
| OA (1) | OA12173A (pt) |
| PL (1) | PL357041A1 (pt) |
| PT (1) | PT1263421E (pt) |
| SK (1) | SK10972002A3 (pt) |
| UA (1) | UA75345C2 (pt) |
| WO (1) | WO2001056556A2 (pt) |
| YU (1) | YU57502A (pt) |
| ZA (1) | ZA200206075B (pt) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1281399A3 (en) * | 2001-08-01 | 2004-02-11 | Warner-Lambert Company | Dual inhibitors of wax ester and cholesteryl ester synthesis for inhibiting sebum production |
| US20050031699A1 (en) | 2003-06-26 | 2005-02-10 | L'oreal | Porous particles loaded with cosmetically or pharmaceutically active compounds |
| ATE409470T1 (de) | 2003-10-09 | 2008-10-15 | Warner Lambert Co | Pharmazeutische zusammensetzungen mit malonamid- derivaten zur verringerung der talg-produktion |
| MX2007010374A (es) | 2005-02-24 | 2007-09-25 | Warner Lambert Co | Inhibidor de acat cristalino. |
| FR2904002A1 (fr) * | 2006-07-19 | 2008-01-25 | Galderma Res & Dev S N C Snc | Modulateurs de la lanosterol synthetase dans le traitement de l'acne ou de l'hyperseborrhee |
| FR2903999B1 (fr) * | 2006-07-19 | 2008-09-05 | Galderma Res & Dev S N C Snc | Modulateurs de sc4mol dans le traitement de l'acne ou de l'hyperseborrhee |
| FR2938342A1 (fr) * | 2008-11-13 | 2010-05-14 | Galderma Res & Dev | Ciblage de modulateurs de ces1 et/ou ces3 dans le traitement de l'acne, d'une dermatite seborrheique ou de l'hyperseborrhee |
| US20100226983A1 (en) | 2009-01-28 | 2010-09-09 | Nanobio Corporation | Compositions for treatment and prevention of acne, methods of making the compositions, and methods of use thereof |
| US20210260055A1 (en) * | 2018-06-21 | 2021-08-26 | Dermavant Sciences GmbH | Topical formulations of dgat1 inhibitors and their methods of use |
Family Cites Families (31)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4545977A (en) * | 1985-01-11 | 1985-10-08 | G. D. Searle & Co. | Compositions and methods for treating severe acne with isotretinoin |
| US4751026A (en) | 1986-03-24 | 1988-06-14 | Warner-Lambert Company | Substituted anilides of oleic, linoleic, or linolenic acid as inhibitors of acyl-coa:cholesterol acyltransferase |
| US4722927A (en) | 1986-04-28 | 1988-02-02 | Warner-Lambert Company | Pyrimidine amides of oleic or linoleic acid, composition containing them and their use as inhibitors of acyl-CoA cholesterol acyltransferase |
| EP0252524A3 (en) | 1986-07-11 | 1989-04-19 | Warner-Lambert Company | Aryl- and aralkylamide- derivatives of omega- (substituted-phenyloxy)-alkanoic acids as inhibitors of acyl-coa: cholesterol acyltransferase and pharmaceuticals containing them |
| US4716175A (en) | 1987-02-24 | 1987-12-29 | Warner-Lambert Company | Saturated fatty acid amides as inhibitors of acyl-CoA:cholesterol acyltransferase |
| IE61716B1 (en) | 1987-06-02 | 1994-11-30 | Warner Lambert Co | Antihyperlipidemic and antiatherosclerotic urea compounds |
| US5015644A (en) | 1987-06-02 | 1991-05-14 | Warner-Lambert Company | Antihyperlipidemic and antiatherosclerotic urea and carbamate compounds |
| ES2037768T3 (es) | 1987-07-02 | 1993-07-01 | Warner-Lambert Company | Procedimiento para preparar n-(fenil(2,6-disustituido))-ureas y carbamatos inhibidores de acil-coa: colesterol acil-transferasa. |
| US4948806A (en) | 1988-03-30 | 1990-08-14 | Warner-Lambert Company | Antihyperlipidemic and antiatherosclerotic compounds and compositions |
| US4868210A (en) | 1988-03-30 | 1989-09-19 | Warner-Lambert Company | Antihyperlipidemic and antiatherosclerotic compounds and compositions |
| US5116848A (en) | 1988-03-30 | 1992-05-26 | Warner-Lambert Company | N-(((2,6-disubstituted)phenyl)-n-diarylalkyl)ureas as antihyperlipidemic and antiatherosclerotic agents |
| US4999373A (en) | 1988-03-30 | 1991-03-12 | Warner-Lambert Company | Antihyperlipidemic and antiatherosclerotic compounds and compositions |
| US5030653A (en) | 1988-03-30 | 1991-07-09 | Warner-Lambert Company | Antihyperlipidemic and antiatherosclerotic compounds and compositions |
| US4923896A (en) | 1989-02-09 | 1990-05-08 | Warner-Lambert Company | N-(substituted aryl)-N'-(substituted alkoxy)-ureas and thioureas as antihypercholesterolemic and antiatherosclerotic agents |
| US5155127A (en) | 1989-02-09 | 1992-10-13 | Warner-Lambert Company | N-(substituted aryl)-n'-(substituted alkoxy)-ureas and thioureas as antihypercholesterolemic and antiatherosclerotic agents |
| US4994465A (en) | 1989-02-17 | 1991-02-19 | Warner-Lambert Company | Antihyperlipidemic and antiatherosclerotic trisubstituted urea compounds |
| AU632809B2 (en) | 1989-05-25 | 1993-01-14 | Takeda Chemical Industries Ltd. | Benzocycloalkane benzopyran and benzothiopyran urea derivatives and production thereof |
| CA2022346A1 (en) | 1989-08-04 | 1991-02-05 | Mitsubishi Chemical Corporation | 1-phenylalkyl-3-phenylurea derivatives |
| WO1991004027A1 (en) | 1989-09-15 | 1991-04-04 | Pfizer Inc. | New n-aryl and n-heteroarylamide and urea derivatives as inhibitors of acyl coenzyme a: cholesterol acyl transferase (acat) |
| TW205037B (pt) | 1989-10-06 | 1993-05-01 | Takeda Pharm Industry Co Ltd | |
| JPH05310678A (ja) | 1990-01-22 | 1993-11-22 | Mitsubishi Kasei Corp | １−フェニルアルキル−３−フェニル尿素誘導体 |
| US5362878A (en) | 1991-03-21 | 1994-11-08 | Pfizer Inc. | Intermediates for making N-aryl and N-heteroarylamide and urea derivatives as inhibitors of acyl coenzyme A: cholesterol acyl transferase (ACAT) |
| ES2125325T3 (es) | 1992-01-23 | 1999-03-01 | Pfizer | Derivados de 4-fenil-3-(heteroarilureido)-1,2-dihidro-2-oxoquinolina como agentes antihipercolesterolemicos y antiateroscleroticos. |
| KR950701621A (ko) | 1992-05-28 | 1995-04-28 | 알렌 제이. 스피겔 | 아실 조효소a : 콜레스테롤 아실 전이효소(acat)의 억제제로서 신규한 n- 아릴 및 n- 헤테로아릴우레아 유도체(new n-aryl and n-heteroarylurea derivatives as inhibitors of acyl coenzyme a : cholesterol acyl transferase(acat) |
| US5565472A (en) | 1992-12-21 | 1996-10-15 | Pfizer Inc. | 4-aryl-3-(heteroarylureido)-1,2-dihydro-2-oxo-quinoline derivatives as antihypercholesterolemic and antiatherosclerotic agents |
| US5491172A (en) | 1993-05-14 | 1996-02-13 | Warner-Lambert Company | N-acyl sulfamic acid esters (or thioesters), N-acyl sulfonamides, and N-sulfonyl carbamic acid esters (or thioesters) as hypercholesterolemic agents |
| US5596001A (en) | 1993-10-25 | 1997-01-21 | Pfizer Inc. | 4-aryl-3-(heteroarylureido)quinoline derivatves |
| US5494172A (en) * | 1994-05-12 | 1996-02-27 | Miller Compressing Company | Magnetic pulley assembly |
| US6133326A (en) * | 1994-08-31 | 2000-10-17 | Pfizer Inc | Compositions and methods for decreasing sebum production |
| EP1090014B1 (en) * | 1998-06-25 | 2003-09-03 | Tularik Inc. | Arylsulfonanilide phosphates |
| AU2001292874B2 (en) * | 2000-09-27 | 2006-06-15 | Merck & Co., Inc. | Benzopyrancarboxylic acid derivatives for the treatment of diabetes and lipid disorders |
-
2001
- 2001-01-23 ES ES01948936T patent/ES2239145T3/es not_active Expired - Lifetime
- 2001-01-23 NZ NZ520330A patent/NZ520330A/en unknown
- 2001-01-23 CN CN01804520A patent/CN1398182A/zh active Pending
- 2001-01-23 IL IL15086501A patent/IL150865A0/xx unknown
- 2001-01-23 WO PCT/US2001/002190 patent/WO2001056556A2/en active IP Right Grant
- 2001-01-23 US US10/182,847 patent/US6730703B2/en not_active Expired - Fee Related
- 2001-01-23 DZ DZ013288A patent/DZ3288A1/fr active
- 2001-01-23 SK SK1097-2002A patent/SK10972002A3/sk not_active Application Discontinuation
- 2001-01-23 EP EP01948936A patent/EP1263421B1/en not_active Expired - Lifetime
- 2001-01-23 UA UA2002076160A patent/UA75345C2/uk unknown
- 2001-01-23 KR KR1020027009943A patent/KR20020073574A/ko not_active Application Discontinuation
- 2001-01-23 AU AU29718/01A patent/AU781563B2/en not_active Ceased
- 2001-01-23 AT AT01948936T patent/ATE295724T1/de not_active IP Right Cessation
- 2001-01-23 HU HU0301010A patent/HUP0301010A3/hu unknown
- 2001-01-23 CA CA002398219A patent/CA2398219A1/en not_active Abandoned
- 2001-01-23 MX MXPA02007309A patent/MXPA02007309A/es active IP Right Grant
- 2001-01-23 JP JP2001556248A patent/JP2003531113A/ja active Pending
- 2001-01-23 YU YU57502A patent/YU57502A/sh unknown
- 2001-01-23 DE DE60110897T patent/DE60110897T2/de not_active Expired - Fee Related
- 2001-01-23 GE GEAP20016597A patent/GEP20043286B/en unknown
- 2001-01-23 PL PL01357041A patent/PL357041A1/xx not_active Application Discontinuation
- 2001-01-23 EA EA200200764A patent/EA004255B1/ru not_active IP Right Cessation
- 2001-01-23 AP APAP/P/2002/002612A patent/AP2002002612A0/en unknown
- 2001-01-23 EE EEP200200429A patent/EE200200429A/xx unknown
- 2001-01-23 PT PT01948936T patent/PT1263421E/pt unknown
- 2001-01-23 OA OA1200200234A patent/OA12173A/en unknown
- 2001-01-23 BR BR0107954-9A patent/BR0107954A/pt not_active Application Discontinuation
-
2002
- 2002-07-19 IS IS6478A patent/IS6478A/is unknown
- 2002-07-24 CR CR6712A patent/CR6712A/es not_active Application Discontinuation
- 2002-07-30 ZA ZA200206075A patent/ZA200206075B/en unknown
- 2002-08-01 NO NO20023659A patent/NO20023659L/no not_active Application Discontinuation
- 2002-08-01 MA MA26756A patent/MA26872A1/fr unknown
- 2002-08-29 BG BG107042A patent/BG107042A/bg unknown
- 2002-08-30 HR HR20020717A patent/HRP20020717A2/hr not_active Application Discontinuation
-
2004
- 2004-02-06 US US10/773,354 patent/US20040161393A1/en not_active Abandoned
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EE200300052A (et) | Kolesterüülestri ülekandevalgu inhibiitorite farmatseutilised kompositsioonid | |
| EE200300169A (et) | Tsüklooksügenaas-2 inhibiitorite kasutamise meetod südame-veresoonkonna haiguste ärahoidmiseks | |
| NO20035632D0 (no) | Selv-emulgerende formuleringer av kolesterylester- overföringsproteininhibitorer | |
| ID27280A (id) | Inhibitor-inhibitor dari enzim-enzim fosfolipase | |
| EE200000488A (et) | Fosfolipaasensüümide inhibiitorid ja farmatseutilised kompositsioonid | |
| DK1105122T3 (da) | Pharmaceutical compositions containing lipase inhibitors | |
| CY2014027I1 (el) | Xρηση διαλκυλο φουμαρικων εστερων | |
| ID29994A (id) | Komposisi farmasi untuk melawan ccr5 terdiri dari turunan anilida | |
| EE200100717A (et) | Indasooliühendid ja farmatseutilised kompositsioonid proteiini kinaaside inhibeerimiseks ja meetodid nende kasutamiseks | |
| DK1252293T3 (da) | Kilde til levervæv | |
| MA26882A1 (fr) | COMPOSITIONS PHARMACEUTIQUES D'INHIBITEURS ET GLYCOGèNE-PHOSPHORYLASE | |
| NO20001648D0 (no) | FremgangsmÕter og mellomprodukter for fremstilling av anti- cancer forbindelser | |
| AU2001280647A1 (en) | Fluorescent agents for real-time measurement of organ function | |
| CY2009001I1 (el) | Νεα μορφη κρυσταλλου του παραγωγου πυρρολιδυλοθειοκαρβαπενεμης | |
| NO20026262D0 (no) | Cyklopentyl-substituerte glutaramidderivater som inhibitorer av nöytral endopeptidase | |
| NO20025377D0 (no) | FremgangsmÕte for fremstilling av dihydroksyestere og derivater derav | |
| EE05020B1 (et) | Glburiidi ravimkoostis | |
| ZA200206032B (en) | Dual inhibitors of wax ester and cholesteryl ester synthesis for inhibiting sebum production. | |
| EE200200429A (et) | Kolesteroolestri ja vahaestri sünteesi duaalsed inhibiitorid rasunäärme häirete jaoks | |
| EE200100611A (et) | NOS inhibiitorite uued farmatseutilised kombinatsioonid | |
| NO20005301D0 (no) | Pyrrolidiner som inhibitorer av neuraminidaser | |
| EE200300468A (et) | Pravastatiini stabiilne farmatseutiline kompositsioon | |
| EE200100084A (xx) | NOS inhibiitorite uued farmatseutilised kasutusv�imalused | |
| NO20014953L (no) | Anvendelse av osanetant for fremstilling av medikamenter anvendt for å behandle sinnsstemningslidelser | |
| AU2001270131A1 (en) | Screen for identifying inhibitors of glycosylphosphatidylnositol anchoring |